Cogniciti and Johnson & Johnson Innovation partner to improve cognitive screenings for early identification of dementia

by

holdingbrainCog­nic­i­ti Announces Col­lab­o­ra­tion with John­son & John­son Inno­va­tion to Eval­u­ate Online Cog­ni­tive Screen­ing to Iden­ti­fy Indi­vid­u­als at Risk for Demen­tia (Bay­crest press release):

“Cog­nic­i­ti Inc., the Toron­to-based devel­op­er of a 20-minute online cog­ni­tive test for adults con­cerned about mem­o­ry changes, today announced a col­lab­o­ra­tion agree­ment with Janssen Phar­ma­ceu­ti­cals, Inc. to eval­u­ate online screen­ing strate­gies for ear­ly iden­ti­fi­ca­tion of dementia.

The col­lab­o­ra­tion, facil­i­tat­ed by John­son & John­son Inno­va­tion, will explore the poten­tial for online psy­cho­me­t­ric tests, such as the Cog­nic­i­ti brain health test, to help iden­ti­fy adults at risk of devel­op­ing demen­tia, includ­ing Alzheimer’s disease…

Adults aged 50–79 are invit­ed to take the test online and receive a sum­ma­ry score rep­re­sent­ing per­for­mance on the cog­ni­tive test imme­di­ate­ly after­ward. Accord­ing to the test’s cre­ators, the major­i­ty of adults con­cerned about Alzheimer’s Dis­ease will score in the nor­mal, healthy range for their age and edu­ca­tion. For the small per­cent­age (approx­i­mate­ly 2 – 3%) that scores below aver­age, those adults will be encour­aged to print their per­son­al­ized report and take it to their doctor…

This col­lab­o­ra­tion agree­ment is an ear­ly demon­stra­tion of the impact of the fed­er­al and Ontario gov­ern­ments’ Cana­di­an Cen­tre for Aging and Brain Health Inno­va­tion (CC-ABHI), announced in May 2015. Cog­nic­i­ti Inc. is one of 40 found­ing part­ners of the CC-ABHI which includes lead­ing indus­try, aca­d­e­m­ic, pub­lic sec­tor and not-for-prof­it organizations.”

To learn more: